Servais Aude
Service de néphrologie adulte, hôpital Necker, université Paris Descartes, 149, rue de Sèvres, 75015 Paris, France.
Nephrol Ther. 2019 Apr;15(2):120-126. doi: 10.1016/j.nephro.2018.11.001. Epub 2019 Jan 15.
Besides its efficiency, lithium has a narrow therapeutic index and can result in considerable toxicity. Among the potential side effects, two types of renal toxicity are observed: a decreased renal concentrating ability and a chronic renal failure. Lithium-induced polyuria is frequent, estimated to affect up to 40% of patients, and develops usually early. It may be irreversible, especially if the treatment has been prescribed for more than 15 years. A chronic renal failure is observed in patients treated for more than 10 to 20 years. Its prevalence is estimated at 12% after 19 years of treatment. Some patients (0.5%) may reach end stage renal disease. The major risk factor is the duration of exposure to lithium. Discussion about stopping or not lithium in case of renal failure needs multidisciplinary expertise and depends on psychiatric status and renal function.
除了其有效性外,锂的治疗指数较窄,可能会导致相当大的毒性。在潜在的副作用中,可观察到两种类型的肾毒性:肾浓缩能力下降和慢性肾衰竭。锂诱导的多尿很常见,估计影响高达40%的患者,且通常在早期出现。它可能是不可逆的,尤其是如果治疗已持续超过15年。在接受治疗超过10至20年的患者中可观察到慢性肾衰竭。治疗19年后其患病率估计为12%。一些患者(0.5%)可能会发展为终末期肾病。主要风险因素是锂暴露的持续时间。对于肾衰竭时是否停用锂的讨论需要多学科专业知识,并取决于精神状态和肾功能。